De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli (Q44449024)

3 December 2017

title

De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli (English)

1 reference

3 December 2017

N Shime

1

1 reference

3 December 2017

T Kosaka

series ordinal

2

1 reference

3 December 2017

N Fujita

series ordinal

3

1 reference

3 December 2017

publication date

20 December 2012

1 reference

3 December 2017

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

203-210

1 reference

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Treatment of Acinetobacter infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Development of a guideline for the management of ventilator-associated pneumonia based on local microbiologic findings and impact of the guideline on antimicrobial use practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Antibiotic utilization: is there an effect on antimicrobial resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Correlation between antibiotic use and resistance in a hospital: temporary and ward-specific observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Principles of antibiotic therapy in severe infections: optimizing the therapeutic approach by use of laboratory and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS15010-012-0388-5

Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay

21 January 2018

1 reference

12 December 2020

Septic shock in bacteremic patients: risk factors, features and prognosis

1 reference

12 December 2020

De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate

1 reference

12 December 2020

Antimicrobial de-escalation in cancer patients

1 reference

12 December 2020

Multidrug-resistant gram-negative pathogens: multiple approaches and measures for prevention

1 reference

12 December 2020

10.1007/S15010-012-0388-5

Identifiers

DOI

1 reference

3 December 2017

1 reference